Arkansas governor Sarah Huckabee Sanders — a former top lieutenant to Donald Trump — is leading a charge against big pharmacy ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. Reduced monthly costs for uninsured patients still amount to around ...

Federal judge blocks Arkansas law barring pharmacy benefit managers from owning pharmacies in state - A federal judge has ...

A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market ...

Obesity drug prices are dropping, but getting a steady supply remains a challenge By TOM MURPHY The Associated Press,Updated July 7, 2025, 1:16 a.m.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. Reduced monthly costs for uninsured patients still amount to around ...

Novo Nordisk’s weight loss drug, Wegovy, is experiencing a surge in new prescriptions following a US ban on its copycat ...

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in ...

By blocking legitimate data-sharing between employers and carriers, underwriters are being pushed into murkier and more ...